Woojung Bio (XKRX:215380) Additional Paid-In Capital : ₩43,201 Mil(As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Woojung Bio Additional Paid-In Capital?

Woojung Bio's quarterly additional paid-in capital stayed the same from Jun. 2023 (₩43,201 Mil) to Sep. 2023 (₩43,201 Mil) and stayed the same from Sep. 2023 (₩43,201 Mil) to Dec. 2023 (₩43,201 Mil).

Woojung Bio's annual additional paid-in capital increased from Dec. 2021 (₩42,741 Mil) to Dec. 2022 (₩43,201 Mil) but then stayed the same from Dec. 2022 (₩43,201 Mil) to Dec. 2023 (₩43,201 Mil).

Woojung Bio Additional Paid-In Capital Historical Data

The historical data trend for Woojung Bio's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Woojung Bio Additional Paid-In Capital Chart

Woojung Bio Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

26,299.36

38,055.96

42,741.50

43,200.83

Woojung Bio Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															43,200.83	43,200.83	43,200.83	43,200.83	43,200.83

Woojung Bio Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Woojung Bio Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Woojung Bio's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Woojung Bio (XKRX:215380) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Woojung Bio Inc (XKRX:215380) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gwanggyo-ro 145, B-dong 3rd Floor, Next Generation Convergence Technology Research Center, Gyeonggi-do, Yeongtong-gu, Suwon-si, KOR

Website

http://bio.woojungbsc.co.kr

Woojung Bio Inc is engaged in the research and development of natural science and engineering. Its products include Gene Delivery, Antibody Production, Immunodeficiency model, Human-to-human model, Zika, Mers, Dengue, Influenza Virus Research, Influenza virus, vaccine studies, and Elegant Goettingen Mini Pig.

Woojung Bio (XKRX:215380) Headlines

No Headlines